Tag Archives: HCVETS

3RD QUARTER BVA DECISIONS JUST RELEASED

Just noticed the BVA snuck in the third quarter decisions about two months late. Hey, it’s the congressional shutdown, right? Well, not exactly. Seems they’ve been bedeviled all year with this problem. I suppose the mere threat of a shutdown … Continue reading

Posted in BvA HCV decisions, Tips and Tricks, Veterans Law | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

SOFOSBUVIR = SOVALDI

Sofosbuvir has a trade name now. It’s Sovaldi and is set for release in early 2014 in Europe. We are awaiting release here in the US with parted lips and straining eyes. Well, I am, anyway. Oh, yeah-the stock is … Continue reading

Posted in HCV Health, Sofosbuvir, Uncategorized | Tagged , , , , , , , , , , , , , , | 2 Comments

JUSTICE DELAYED IS NOT JUSTICE DENIED

March 31, 1994 submit claims for: 1) Porphyria Cutanea Tarda (PCT), secondary to a)Hepatitis or b)Agent orange 2) tinnitus increase to compensable (10%) _________________________________ November 4, 1994 Receive denials for: 1) residuals of hepatitis (nothing in SMRs) 2) PCT due … Continue reading

Posted in BvA HCV decisions, Remanded claims, Veterans Law | Tagged , , , , , , , , , , , , , | 3 Comments

VETERANS DAY DISCOUNTS

One day a year America recognizes her Veterans on this side of the grass. Memorial Day is for the ones on the other side who have reached room temperature. Regardless, there is much hoopla. Veterans are getting to be big … Continue reading

Posted in All about Veterans, Food for thought, vA news | Tagged , , , , , , , , | Leave a comment

“Veterans Affairs Research Supports CDC Recommendation to Screen Baby Boomers for Hepatitis C”

The “Liver Meeting 2013” conference in DC ends tomorrow. The sponsor of the meeting, the American Association of the Study of Liver Diseases(AASLD), released a press release (11/3/13) on the research of Lisa Backus, M.D., Ph.d. from the VA. As … Continue reading

Posted in Guest authors, HCV Health, HCV Risks (documented) | Tagged , , , , , , , , , , , , , , , , , | 4 Comments

Hepatitis C replication increased during pregnancy according to recent study

 An abstract of a study just published in Nature signals   that mainstream medical associations, like the American Congress of Obstetricians and Gynecologists (ACOG), should become proactive by screening for HCV routinely rather than by known risk-factors.  “Loss of immune escape mutations during persistent … Continue reading

Posted in Guest authors, HCV Health | Tagged , , , , , , , , , , , , , , , , | Leave a comment

SOFOSBUVIR HITS 85% IN SVR24 TRIALS

Now we’re talking, ladies and gentlemen. When I entered this arena in 1995, less than 33% were achieving any kind of success and some relapsed years after. The pegylated Interferon (PegIntron) of the early to mid 2000s again only hit … Continue reading

Posted in HCV Health | Tagged , , , , , , , , , , , , , , , , | 4 Comments

VERTEX ON THE WAY OUT

I spotted this on the wire this morning. It was inevitable and I wondered when the boys at Vertex would pull up the stakes and fold the tent. The only sad facet of this is how many lives were inadvertently … Continue reading

Posted in HCV Health, research, VA Health Care | Tagged , , , , , , , , , , , , , , , , | 4 Comments

SOFOSBUVIR DECLARED LEGAL

Today the FDA approved what I pray is the cure for my illness 15-0 with nary a naysayer among them. Hepatitis C sufferers who failed the Interferon prophylaxis over the years now have one good shot at killing the dragon.  … Continue reading

Posted in HCV Health, Medical News, research | Tagged , , , , , , , , , , , , , , , , , | 8 Comments

SOFOSBUVIR–HOT OFF THE WIRE

We had expected glowing reports this Friday after the FDA review of the new HCV Gilead drug Sofosbuvir. What, then, to our utter surprise than to spot this promising FDA blurb today- three days prior to the upcoming FDA discourse. … Continue reading

Posted in HCV Health, Medical News | Tagged , , , , , , , , , , , , , , , , , , | 3 Comments